1月14日下午2:00，仁醫(yī)醫(yī)療三人團隊到達慕尼黑工業(yè)大學(xué)附屬醫(yī)院拜訪血液與腫瘤科Lorenzen教授。Lorenzen教授專注于胃腸道癌癥多模式治療、實體瘤治療反應(yīng)評估及癌癥I期臨床試驗等，并擔任多個國內(nèi)、國際學(xué)術(shù)職位。Lorenzen教授是德國癌癥協(xié)會腫瘤內(nèi)科學(xué)工作組（AIO）胃癌工作組主席，慕尼黑工業(yè)大學(xué)附屬醫(yī)院早期臨床試驗組（ECTU）負責人。她所在的血液與腫瘤科為患者提供的診療方案達到了最新的國際化水平，科室配備有專業(yè)團隊為每位腫瘤患者量身打造最現(xiàn)代化的治療方案?？剖已号c免疫分型實驗室的干細胞實驗室還獲得了巴伐利亞州政府認證。此外，該科室十分重視院內(nèi)外的多學(xué)科合作。院內(nèi)，他們與跨學(xué)科腫瘤治療中心（TTZ）密切配合；院外，他們也與慕尼黑綜合癌癥中心（CCCM）及德國癌癥轉(zhuǎn)化研究聯(lián)合學(xué)會（DKTK）緊密聯(lián)系。據(jù)Lorenzen教授介紹，科室團隊還與法蘭克福大學(xué)腫瘤疾病中心（UCT）的腫瘤臨床研究所（IKF）合作，在上胃腸道疾病領(lǐng)域進行了許多臨床實驗。Lorenzen教授本人同樣活躍于臨床研究，并發(fā)表了多篇高影響力學(xué)術(shù)論文，積極推動全球腫瘤醫(yī)學(xué)發(fā)展。2024年，Lorenzen教授加入了仁醫(yī)醫(yī)療的德國臨床醫(yī)學(xué)MD博士項目合作，2024年11月8日教授與來自貴陽的羅醫(yī)生進行了面試，并在今年1月為她發(fā)了邀請函，正式接收她為臨床醫(yī)學(xué)MD博士，她將積極幫助羅醫(yī)生于2025年3月份申請中國留學(xué)基金委（CSC）獎學(xué)金。2025年11月Lorenzen教授將來到中國參加第五屆中歐醫(yī)院管理學(xué)科建設(shè)人才培養(yǎng)全球論壇，她表示非常期待來到中國與中國同道們交流分享相關(guān)經(jīng)驗。

At 2 p.m. on the afternoon of January 14 , the team of three from Gloryren arrived at the Klinikum Rechts der Isar of Technical University of Munich to visit Prof. Lorenzen of the Department of Hematology and Oncology. Prof. Lorenzen focuses on the response evaluation in solid tumour therapy, multimodality treatment of gastrointestinal cancer and Phase I clinical trials. She also holds many positions in national and international scientific organizations. Prof. Lorenzen is the Vice Chair of the Gastric Cancer Task Force of the Internal Oncology Working Group (AIO) of German Cancer Society and the Head of the Early Clinical Trial Unit (ECTU) of the Klinikum Rechts der Isar of Technical University of Munich. The Department of Hematology and Oncology, where Prof. Lorenzen works in, offers patient care with the latest international level. The department is equipped with a professional team to provide the most modern treatment plan for each patient. The stem cell laboratory of the department’s Hematology and Immunophenotyping Laboratory is certified by the Bavarian Government. Additionally, the department places great value on interdisciplinary cooperation. Internally, they establish close cooperation with the Interdisciplinary Tumor Therapy Center (TTZ). Externally, they keep close contact with Comprehensive Cancer Center Munich (CCCM) and the German Consortium for Translational Cancer Research (DKTK). According to Prof. Lorenzen, the department conducts many clinical trials on upper gastrointestinal tumors in collaboration with the Institute for Clinical Cancer Research (IKF) of the Comprehensive Cancer Centers of the University Hospital Frankfurt (UCT).Prof. Lorenzen has been active in clinical research and has published many high-impact academic papers, actively promoting the development of oncology from a global perspective. In 2024, Prof. Lorenzen established a cooperation with Gloryren on MD project and interviewed Doctor Luo from Guiyang, Guizhou Province, on November 8, 2024.In January, she issued an invitation for Doctor Luo and accepted her as an MD student, and she will support Luo to apply for the CSC scholarship in March 2025.Prof. Lorenzen will visit China to attend the 5th Sino-Euro Global Forum on Hospital Management, Specialty Construction and Talent Cultivation in November 2025. She is looking forward to visiting China and to sharing her valuable insights with Chinese colleagues.